Future studies to examine LIMD1 and its function in cardiac fibroblasts in combination with SKI’s role in fibroblast physiology may lead to the generation of data that could be exploited for selective therapeutic targeting in cardiac fibrosis and heart failure. The gene discussed is LIMD1; the disease is heart failure.